Intensity Therapeutics to Participate in the LD Micro Invitational XIV Conference April 8

/PRNewswire/ -- Intensity Therapeutics, Inc. (Nasdaq: INTS), a late-stage clinical biotechnology company focused on the discovery and development of...

Related Keywords

New York ,United States ,Justin Kulik ,Jules Abraham ,Lewish Bender ,Intensity Therapeutics Inc ,Sofitel Hotel ,Nasdaq ,Intensity Therapeutics ,Chief Executive Officer ,Dean Summers ,Relations Contact ,